Wolverine Asset Management LLC Incyte Corp Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $1,444 - $1,909	-19 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $1,534 - $1,856	19 New	19 $1,000
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $1,701 - $2,193	-20 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $28,707 - $42,155	-387 Reduced 95.09%	20 $2,000
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $1.06 Million - $1.32 Million	-11,280 Reduced 96.52%	407 $38,000
Q3 2017 Nov 14, 2017	SELL	$109.15 - $138.27 $470,763 - $596,358	-4,313 Reduced 26.96%	11,687 $1.36 Million
Q2 2017 Aug 14, 2017	BUY	N/A	16,000	16,000 $2.01 Million

641

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.